These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10947440)
21. [Rare primary hepatic neoplasms. Our experience in 2 cases: a primary lymphoma and a leiomyosarcoma of the liver]. Spagliardi E; Longo A; Blanco GF; Ruggeri C; Buscaglia M; Torelli P Minerva Chir; 1990 Jan; 45(1-2):95-102. PubMed ID: 2186303 [TBL] [Abstract][Full Text] [Related]
22. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma]. Ogura M Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928 [No Abstract] [Full Text] [Related]
23. [Effective combined modality therapy for a patient with primary adrenal lymphoma]. Shirao S; Kuroda H; Kida M; Watanabe H; Matsunaga T; Niitsu Y; Konuma Y; Hirayama Y; Kohda K Rinsho Ketsueki; 2006 Mar; 47(3):204-9. PubMed ID: 16629485 [TBL] [Abstract][Full Text] [Related]
24. A male with primary breast lymphoma. Miura Y; Nishizawa M; Kaneko H; Watanabe M; Tsudo M Am J Hematol; 2009 Mar; 84(3):191-2. PubMed ID: 18932237 [No Abstract] [Full Text] [Related]
25. Lactic Acidosis in Non-Hodgkin's Lymphoma and response to Chemotherapy. Osorio S; Bernis C; de La Cámara R Haematologica; 2002 Feb; 87(2):ELT05. PubMed ID: 11836182 [No Abstract] [Full Text] [Related]
27. Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP. Bosly A; Bron D; Van Hoof A; De Bock R; Berneman Z; Ferrant A; Kaufman L; Dauwe M; Verhoef G Ann Hematol; 2008 Apr; 87(4):277-83. PubMed ID: 17952688 [TBL] [Abstract][Full Text] [Related]
28. Diffuse large B-cell lymphoma. Ng AK Semin Radiat Oncol; 2007 Jul; 17(3):169-75. PubMed ID: 17591563 [TBL] [Abstract][Full Text] [Related]
30. Primary mediastinal large B-cell lymphoma. Ergul SM; Lal A; Afri L; Frei-Lahr D South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098 [TBL] [Abstract][Full Text] [Related]
31. Primary diffuse large B-cell non-Hodgkin lymphoma of the paranasal sinuses: a report of 14 cases. Oprea C; Cainap C; Azoulay R; Assaf E; Jabbour E; Koscielny S; Lapusan S; Vanel D; Bosq J; Ribrag V Br J Haematol; 2005 Nov; 131(4):468-71. PubMed ID: 16281936 [TBL] [Abstract][Full Text] [Related]
32. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285 [TBL] [Abstract][Full Text] [Related]
33. Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies. Pinnix CC Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):641-4. PubMed ID: 26972636 [No Abstract] [Full Text] [Related]
34. Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma. Hornberger JC; Best JH Cancer; 2005 Apr; 103(8):1644-51. PubMed ID: 15756658 [TBL] [Abstract][Full Text] [Related]
35. Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients. Park YH; Lee JJ; Ryu MH; Kim SY; Kim DH; Do YR; Lee KH; Oh SJ; Kim YK; Suh CW; Heo DS; Ryoo BY; Kim JK; Song HS; Lee WS; Kim HJ; Bang YJ; Yang SH; Sohn SK; Kang YK; Ann Hematol; 2006 Apr; 85(4):257-62. PubMed ID: 16416337 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120 [TBL] [Abstract][Full Text] [Related]
38. Diffuse large B-cell lymphoma with fibrillary matrix. Dargent JL; Meiers I; Lespagnard L; Ma Y; Dehou MF; Verhest A Diagn Cytopathol; 2002 Oct; 27(4):223-6. PubMed ID: 12357500 [TBL] [Abstract][Full Text] [Related]
39. Is CHOP the standard of therapy for poor-prognosis large-cell lymphoma? Canellos GP Ann Oncol; 1997; 8 Suppl 1():61-2. PubMed ID: 9187432 [No Abstract] [Full Text] [Related]
40. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]